Integrative Health Solutions logoIntegrative HealthSOLUTIONS

Recovery & Repair

KPV

The C-terminal tripeptide of alpha-MSH, studied for inflammatory modulation without the pigmentary effects of the parent hormone.

Hands preparing a nourishing grain and vegetable bowl
Format
50mg vial — 10mg/mL, 5mL injectable
Price
$220 per vial
Route
Injectable
Evidence level
Preclinical
Regulatory status
Compounded
Testing
Provider Determines Testing

Pricing reflects the compounded preparation and doctor review. Final therapy and dosing are determined only after your intake is reviewed.

Overview

Understanding KPV

What is KPV?

KPV is a three-amino-acid fragment (lysine-proline-valine) of alpha-melanocyte-stimulating hormone. Research interest centers on its inflammatory signaling activity, particularly in gastrointestinal and dermatologic contexts.

Format & administration

Prescribed as a daily subcutaneous injection.

Testing posture

Your doctor determines the final testing requirements for KPV after reviewing your intake. The panels below are what is commonly reviewed for this therapy — they are educational guidance, not a fixed requirement.

How it works

How KPV works

  1. 01Preclinical work suggests KPV may act intracellularly on inflammatory transcription pathways in epithelial and immune cells, which is why it is often discussed for mucosal tissue rather than systemic immunosuppression.
Show illustration: KPV
KPV: proposed mechanism, physiology, and reported clinical effects. Educational illustration — not a treatment guarantee.

What has been studied

Potential applications and evidence

These areas are commonly discussed within wellness-focused protocols. They are educational statements, not medical claims or guarantees of outcome.

Explored within gut-focused wellness protocols
Discussed for inflammatory skin concerns
Potential support for immune balance
Frequently paired with BPC-157 for gut protocols

Doctor-guided

A personalized approach

Your doctor determines the final testing requirements for KPV after reviewing your intake. The panels below are what is commonly reviewed for this therapy — they are educational guidance, not a fixed requirement.

Bloodwork status: Provider Determines Testing

Commonly reviewed at baseline

  • CBC
  • Comprehensive metabolic panel (CMP)
  • hs-CRP

Follow-up & monitoring

Symptom-led follow-up. Inflammatory markers may be repeated if they were abnormal before starting.

Medication review

Your doctor reviews all prescriptions, supplements, and over-the-counter medications during intake before anything is prescribed.

Format & dosing

Prescribed as a daily subcutaneous injection.

Safety

What patients should know

  • Compounded medication, not FDA-approved. Review autoimmune conditions and immunosuppressive medications with your doctor before starting.

Who may not be a candidate

  • Pregnancy or nursing
  • Active malignancy without oncology clearance
  • Known hypersensitivity to the preparation

Regulatory status: Compounded. Evidence level: Preclinical. Eligibility, dosing, laboratory requirements, and follow-up care are determined exclusively by a licensed doctor after review of your history.

Common questions

Frequently asked questions

Ready when you are

Find out what your body is actually asking for.

Fill out a short intake form and our care team will build a plan grounded in your labs — not a guess from a supplement aisle.